{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T13:20:55Z","timestamp":1649164855855},"reference-count":22,"publisher":"Informa UK Limited","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["vaccines"],"published-print":{"date-parts":[[2013,12,1]]},"DOI":"10.4161\/hv.26096","type":"journal-article","created":{"date-parts":[[2013,9,11]],"date-time":"2013-09-11T19:27:12Z","timestamp":1378927632000},"page":"2578-2583","source":"Crossref","is-referenced-by-count":1,"title":["Infection-enhancing lipopeptides do not improve intranasal immunization of cotton rats with a delta-G candidate live-attenuated human respiratory syncytial virus vaccine"],"prefix":"10.1080","volume":"9","author":[{"given":"D","family":"Tien Nguyen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jolande","family":"Boes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert","family":"van Amerongen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvonne","family":"van Remmerden","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Selma","family":"Y\u00fcksel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Teun","family":"Guichelaar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albert DME","family":"Osterhaus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rik L","family":"de Swart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"301","reference":[{"key":"R1","unstructured":"Collins PL. Human respiratory syncytial virus. In: Samal, S. K. ed. The biology of paramyxoviruses. Norfolk (UK): Caister Academic Press, 2011:341-410."},{"key":"R2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.virusres.2011.09.020","article-title":"Progress in understanding and controlling respiratory syncytial virus: still crazy after all these years","volume":"162","author":"Collins","year":"2011","journal-title":"Virus Res"},{"key":"R3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1128\/CMR.00032-09","article-title":"Respiratory viral infections in infants: causes, clinical symptoms, virology, and immunology","volume":"23","author":"Tregoning","year":"2010","journal-title":"Clin Microbiol Rev"},{"key":"R4","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1600-065X.2010.00972.x","article-title":"Biological challenges and technological opportunities for respiratory syncytial virus vaccine development","volume":"239","author":"Graham","year":"2011","journal-title":"Immunol Rev"},{"key":"R5","doi-asserted-by":"crossref","first-page":"B209","DOI":"10.1016\/j.vaccine.2012.11.106","article-title":"Strategic priorities for respiratory syncytial virus (RSV) vaccine development","volume":"31","author":"Anderson","year":"2013","journal-title":"Vaccine"},{"key":"R6","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/oxfordjournals.aje.a120955","article-title":"Respiratory syncytial virus disease in infants despite prior administration of antigenic inactivated vaccine","volume":"89","author":"Kim","year":"1969","journal-title":"Am J Epidemiol"},{"key":"R7","doi-asserted-by":"crossref","DOI":"10.1007\/s12016-013-8368-9","article-title":"Respiratory Syncytial Virus-A Comprehensive Review","author":"Borchers","year":"2013","journal-title":"Clin Rev Allergy Immunol"},{"key":"R8","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.jcv.2007.10.024","article-title":"Respiratory syncytial virus (RSV) vaccines--two steps back for one leap forward","volume":"41","author":"Power","year":"2008","journal-title":"J Clin Virol"},{"key":"R9","doi-asserted-by":"crossref","first-page":"e1001049","DOI":"10.1371\/journal.ppat.1001049","article-title":"The synthetic bacterial lipopeptide Pam3CSK4 modulates respiratory syncytial virus infection independent of TLR activation","volume":"6","author":"Nguyen","year":"2010","journal-title":"PLoS Pathog"},{"key":"R10","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1172\/JCI20762","article-title":"Antagonistic antibody prevents toll-like receptor 2-driven lethal shock-like syndromes","volume":"113","author":"Meng","year":"2004","journal-title":"J Clin Invest"},{"key":"R11","doi-asserted-by":"crossref","first-page":"3823","DOI":"10.4049\/jimmunol.181.6.3823","article-title":"Staphylococcus aureus-induced plasmacytoid dendritic cell activation is based on an IgG-mediated memory response","volume":"181","author":"Parcina","year":"2008","journal-title":"J Immunol"},{"key":"R12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/BF01317851","article-title":"Bovine respiratory syncytial virus infection of bovine embryonic lung cultures: enhancement of infectivity with diethylaminoethyl-dextran and virus-infected cells","volume":"56","author":"Rossi","year":"1978","journal-title":"Arch Virol"},{"key":"R13","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/j.cell.2007.10.014","article-title":"Semen-derived amyloid fibrils drastically enhance HIV infection","volume":"131","author":"M\u00fcnch","year":"2007","journal-title":"Cell"},{"key":"R14","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1128\/JVI.01366-08","article-title":"The cationic properties of SEVI underlie its ability to enhance human immunodeficiency virus infection","volume":"83","author":"Roan","year":"2009","journal-title":"J Virol"},{"key":"R15","doi-asserted-by":"crossref","first-page":"5073","DOI":"10.1016\/j.vaccine.2012.05.079","article-title":"Evaluation of synthetic infection-enhancing lipopeptides as adjuvants for a live-attenuated canine distemper virus vaccine administered intra-nasally to ferrets","volume":"30","author":"Nguyen","year":"2012","journal-title":"Vaccine"},{"key":"R16","doi-asserted-by":"crossref","first-page":"13649","DOI":"10.1128\/JVI.01385-07","article-title":"Development of a challenge-protective vaccine concept by modification of the viral RNA-dependent RNA polymerase of canine distemper virus","volume":"81","author":"Silin","year":"2007","journal-title":"J Virol"},{"key":"R17","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/1743-422X-7-114","article-title":"A highly attenuated recombinant human respiratory syncytial virus lacking the G protein induces long-lasting protection in cotton rats","volume":"7","author":"Widjojoatmodjo","year":"2010","journal-title":"Virol J"},{"key":"R18","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1186\/1743-422X-9-253","article-title":"An improved respiratory syncytial virus neutralization assay based on the detection of green fluorescent protein expression and automated plaque counting","volume":"9","author":"van Remmerden","year":"2012","journal-title":"Virol J"},{"key":"R19","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jviromet.2013.06.016","article-title":"Paramyxovirus infections in ex vivo lung slice cultures of different host species","volume":"193","author":"Nguyen","year":"2013","journal-title":"J Virol Methods"},{"key":"R20","doi-asserted-by":"crossref","first-page":"1782","DOI":"10.1016\/j.bpj.2010.01.012","article-title":"Characterization of particle translocation through mucin hydrogels","volume":"98","author":"Lieleg","year":"2010","journal-title":"Biophys J"},{"key":"R21","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1111\/j.1469-0691.2011.03480.x","article-title":"Streptococcus pneumoniae exposure is associated with human metapneumovirus seroconversion and increased susceptibility to in vitro HMPV infection","volume":"17","author":"Verkaik","year":"2011","journal-title":"Clin Microbiol Infect"},{"key":"R22","doi-asserted-by":"crossref","first-page":"10508","DOI":"10.1128\/JVI.74.22.10508-10513.2000","article-title":"Glycosaminoglycan sulfation requirements for respiratory syncytial virus infection","volume":"74","author":"Hallak","year":"2000","journal-title":"J Virol"}],"container-title":["Human vaccines & immunotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.tandfonline.com\/doi\/pdf\/10.4161\/hv.26096","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,24]],"date-time":"2019-07-24T00:05:09Z","timestamp":1563926709000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.landesbioscience.com\/journals\/vaccines\/article\/26096\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12,1]]},"references-count":22,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2013,12,1]]}},"URL":"https:\/\/doi.org\/10.4161\/hv.26096","relation":{},"ISSN":["2164-5515","2164-554X"],"issn-type":[{"value":"2164-5515","type":"print"},{"value":"2164-554X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,12,1]]}}}